In Brief: FDA consolidated campuses
FDA consolidated campuses: Senate could rescind $248 mil. of funds previously appropriated to the General Services Administration Federal Buildings Fund for the purpose of buying land and beginning construction of the two proposed Maryland campuses in Montgomery and Prince George's counties through an amendment to the Federal Emergency Management Agency supplemental appropriations bill. In an April 6 statement, Sen. Mikulski (D-Md.) called the action "penny wise and pound foolish." She also stated: "I am going to fight for the modernization of the FDA because [it] enables us to save lives and generate jobs." The estimated total cost of the campuses is $810 mil...
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth